1
|
Queval CJ, Song OR, Carralot JP, Saliou JM, Bongiovanni A, Deloison G, Deboosère N, Jouny S, Iantomasi R, Delorme V, Debrie AS, Park SJ, Gouveia JC, Tomavo S, Brosch R, Yoshimura A, Yeramian E, Brodin P. Mycobacterium tuberculosis Controls Phagosomal Acidification by Targeting CISH-Mediated Signaling. Cell Rep 2018; 20:3188-3198. [PMID: 28954234 PMCID: PMC5637157 DOI: 10.1016/j.celrep.2017.08.101] [Citation(s) in RCA: 34] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2017] [Revised: 07/29/2017] [Accepted: 08/30/2017] [Indexed: 11/29/2022] Open
Abstract
Pathogens have evolved a range of mechanisms to counteract host defenses, notably to survive harsh acidic conditions in phagosomes. In the case of Mycobacterium tuberculosis, it has been shown that regulation of phagosome acidification could be achieved by interfering with the retention of the V-ATPase complexes at the vacuole. Here, we present evidence that M. tuberculosis resorts to yet another strategy to control phagosomal acidification, interfering with host suppressor of cytokine signaling (SOCS) protein functions. More precisely, we show that infection of macrophages with M. tuberculosis leads to granulocyte-macrophage colony-stimulating factor (GM-CSF) secretion, inducing STAT5-mediated expression of cytokine-inducible SH2-containing protein (CISH), which selectively targets the V-ATPase catalytic subunit A for ubiquitination and degradation by the proteasome. Consistently, we show that inhibition of CISH expression leads to reduced replication of M. tuberculosis in macrophages. Our findings further broaden the molecular understanding of mechanisms deployed by bacteria to survive. M. tuberculosis interferes with host pathways to control vacuolar acidification Infection induces the expression of host CISH and recruitment to the phagosome CISH triggers the degradation of H+-V-ATPase via SOCS box-mediated ubiquitination This defense mechanism complements previous schemes relying on virulence factors
Collapse
Affiliation(s)
- Christophe J Queval
- University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 8204, CIIL-Center for Infection and Immunity of Lille, 59000 Lille, France; Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, 75015 Paris, France
| | - Ok-Ryul Song
- University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 8204, CIIL-Center for Infection and Immunity of Lille, 59000 Lille, France; Institut Pasteur Korea, 16 Daewangpangyo-ro 712 beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do 463-400, South Korea
| | - Jean-Philippe Carralot
- Institut Pasteur Korea, 16 Daewangpangyo-ro 712 beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do 463-400, South Korea
| | - Jean-Michel Saliou
- University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 8204, CIIL-Center for Infection and Immunity of Lille, 59000 Lille, France; Plateforme de Protéomique et Peptides Modifiés (P3M), CNRS, Institut Pasteur de Lille, University Lille, 59000 Lille, France
| | - Antonino Bongiovanni
- University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 8204, CIIL-Center for Infection and Immunity of Lille, 59000 Lille, France
| | - Gaspard Deloison
- University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 8204, CIIL-Center for Infection and Immunity of Lille, 59000 Lille, France
| | - Nathalie Deboosère
- University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 8204, CIIL-Center for Infection and Immunity of Lille, 59000 Lille, France
| | - Samuel Jouny
- University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 8204, CIIL-Center for Infection and Immunity of Lille, 59000 Lille, France
| | - Raffaella Iantomasi
- University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 8204, CIIL-Center for Infection and Immunity of Lille, 59000 Lille, France
| | - Vincent Delorme
- University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 8204, CIIL-Center for Infection and Immunity of Lille, 59000 Lille, France; Institut Pasteur Korea, 16 Daewangpangyo-ro 712 beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do 463-400, South Korea
| | - Anne-Sophie Debrie
- University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 8204, CIIL-Center for Infection and Immunity of Lille, 59000 Lille, France
| | - Sei-Jin Park
- Institut Pasteur Korea, 16 Daewangpangyo-ro 712 beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do 463-400, South Korea
| | - Joana Costa Gouveia
- University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 8204, CIIL-Center for Infection and Immunity of Lille, 59000 Lille, France
| | - Stanislas Tomavo
- University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 8204, CIIL-Center for Infection and Immunity of Lille, 59000 Lille, France; Plateforme de Protéomique et Peptides Modifiés (P3M), CNRS, Institut Pasteur de Lille, University Lille, 59000 Lille, France
| | - Roland Brosch
- Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, 75015 Paris, France
| | - Akihiko Yoshimura
- Department of Microbiology and Immunology, Keio University School of Medicine, 35 Shinanomachi, Shinjyuku-ku, Tokyo 160-8582, Japan
| | - Edouard Yeramian
- Unité de Microbiologie Structurale, CNRS UMR3528 Institut Pasteur, 75015 Paris, France.
| | - Priscille Brodin
- University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 8204, CIIL-Center for Infection and Immunity of Lille, 59000 Lille, France; Institut Pasteur Korea, 16 Daewangpangyo-ro 712 beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do 463-400, South Korea.
| |
Collapse
|